comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 21:09:56 - browse：11974

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： ACA's risk program benefits Blue Cross Blue Shield insurers

Wikipedia

WSS

Biden targets hefty hospital 'facility fees' that often surprise patients

Eliminate the waiting period for sterilization covered by Medicaid

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Scientists boost immune system in aging mice by making it youthful

Biden’s NIH nominee is languishing in Congress

explore

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Presidential fundraising highlights so far: Trump brings in more than DeSantis

In age of alternative facts, a scholarly course on calling out crap

The Readout: Lenmeldy, GLP

Medical records are filled with copy

Biden’s NIH nominee is languishing in Congress

George Santos makes 1st court appearance after pleading not guilty to 13 counts

There's no autism epidemic. It's an autism diagnosis epidemic

New air purifier tech could be key to improving indoor air quality

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

focus

ACA's risk program benefits Blue Cross Blue Shield insurers

Food as medicine: Medically tailored meals may get standardized

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

States should stop sabotaging methadone treatment reform

Why the world’s most expensive drug might be worth the price

White House announces new plan to address the growing threat of xylazine in overdose crisis

hotspot

Wikipedia

explore

focus